The rodent nongenotoxic hepatocarcinogen and peroxisome proliferator nafenopin inhibits intercellular communication in rat but not guinea-pig hepatocytes, perturbing S-phase but not apoptosis

Archives of Toxicology

Volumn 72, Issue 7, 1998, Pages 439-444

  Elcock, Fiona J ^a   Chipman, J Kevin ^a   Roberts, Ruth A ^b  

^a UNIVERSITY OF BIRMINGHAM   (United Kingdom)

^b ASTRAZENECA   (United Kingdom)

Author keywords

Apoptosis; Gap junctional intercellular communication; Nongenotoxic carcinogenesis; Peroxisome proliferators; S phase

Indexed keywords

NAFENOPIN; PEROXISOME PROLIFERATOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CELL COMMUNICATION; CONTROLLED STUDY; DNA SYNTHESIS; GUINEA PIG; LIVER CARCINOGENESIS; LIVER CELL; LIVER TUMOR; NONHUMAN; PRIORITY JOURNAL; RAT;

ANIMALS; APOPTOSIS; CARCINOGENS; CELL COMMUNICATION; GAP JUNCTIONS; GUINEA PIGS; LIVER; MALE; NAFENOPIN; RATS; RATS, WISTAR; S PHASE;

ANIMALIA; CAVIA PORCELLUS; RODENTIA; SUS SCROFA;

EID: 0031837090     PISSN: 03405761     EISSN: None     Source Type: Journal    
DOI: 10.1007/s002040050524     Document Type: Article

References (37)

1. Ames BN, Gold LS (1990) Too many rodent carcinogens: mitogenesis increases mutagenesis. Science 249: 970-971
2. Ashby J, Tennant R (1991) Definitive relationships among chemical structure, carcinogenicity and mutagenicity for 301 chemicals tested by the U.S. NTP. Mutat Res 257: 229-306
3. Ashby J, Brady A, Elcombe CR, Elliot BM, Ishmael J, Odum J, Tugwood JD, Kettle S, Purchase IFH (1994) Mechanistically-based human hazard assessment of peroxisome-proliferator-induced hepatocarcinogenesis. Hum Exp Toxicol 13: S1-S117
4. Barber ED, Astill BD, Moran EJ, Schneider BF, Gray TJB, Lake BG, Evans JG (1987) Peroxisome induction studies on seven phthalate esters. Toxicol Indust Health 3: 130
5. Bayly AC, Roberts RA, Dive C (1994) Suppression of liver cell apoptosis in vitro by the non-genotoxic hepatocarcinogen and peroxisome proliferator, nafenopin. J Cell Biol 125: 197-203
6. Bennett MVL, Barrio LC, Bargiello TA, Spray DC, Hertzberg E, Saez JC (1991) Gap junctions: new tools, new answers, new questions. Neuron 6: 305-320
7. Bentley P, Calder I, Elcombe C, Grasso P, Wiegand HG, Stringer DA (1992) Hepatic peroxisome proliferation. European Chemical Industry Ecology and Toxicology Centre Monograph 17
8. Bieri F, Bentley P, Waechter F, Staubli W (1984) Use of primary cultures of adult rat hepatocytes to investigate mechanisms of action of nafenopin, a hepatocarcinogenic peroxisome proliferator. Carcinogenesis 5: 1033-1039
9. Elcock FJ, Roberts RA, Chipman JK (1997) Time and concentration-dependency of inhibition of gap junction communication by nafenopin in rat hepatocytes. Hum Exp Toxicol 16: 45
10. Elcombe CR (1985) Species differences in carcinogenicity and peroxisome proliferation due to trichloroethylene: a biochemical human hazard assessment. Arch Toxicol (Suppl) 8: 6-17
11. Holder PR, Tugwood JD (1998) Peroxisome proliferator activated receptor alpha: cancer and species differences. J Mol Endocrinol (in press)
12. James NH, Roberts RA (1996) Species differences in response to peroxisome proliferators correlate in vitro with induction of DNA synthesis rather than with suppression of apoptosis. Carcinogenesis 17: 1623-1632
13. Lake BG, Evans JG, Gray TJB, Korosi SA, North CJ (1989) Comparative studies on nafenopin-induced hepatic peroxisome proliferation in the rat, syrian hamster, guinea-pig and marmoset. Toxicol Appl Pharmacol 99: 148-160
14. Leibold E, Schwarz LR (1993) Inhibition of intercellular communication in rat hepatocytes by nafenopin: involvement of protein kinase C. Carcinogenesis 15: 1265-1269
15. Lowenstein WR (1979) Junctional intercellular communication and the control of growth. Biochim Biophys Acta 101: 1-65
16. Marsman DS, Russell CC, Cattley RC, Conway JG, Popp JA (1988) Relationship of hepatic peroxisome proliferation and replicative DNA synthesis to the hepatocarcinogenicity of the peroxisome proliferators di(2-ethylhexyl)phthalate and [4-chloro-6-(2,3-xylidino)-2-pyramidinylthio]acetic acid (Wy14,643) in rats. Cancer Res 48: 6739-6744
17. Mesnil M, Montesano R, Yamasaki H (1986) Intercellular communication of transformed and non-transformed rat liver epithelial cells. Exp Cell Res 165: 391-402
18. Mesnil M, Krutovskikh V, Omori Y, Yamasaki H (1995) Role of blocked gap junctional intercellular communication in non-genotoxic carcinogenesis. Toxicol Lett 82/83: 701-706
19. Moody DE, Reddy JK, Lake BG, Popp JA, Reese DH (1991) Peroxisome proliferation and non-genotoxic carcinogenesis: commentary on a symposium. Fundam Appl Toxicol 6: 233-248
20. Musil LAS, Goodenough DA (1990) Gap Junctional intercellular communication and the regulation of connexin expression and function. Curr Opin Cell Biol 2: 875-880
21. Orellana A, Holuigue L, Hidalgo PC, Faundez V, Gonzalez A, Bronfman M (1993) Ciprofibrate, a carcinogenic peroxisome proliferator, increases the phosphorylation of the epidermal growth factor receptor. Eur J Biochem 215: 903-906
22. Passilly P, Jannin B, Latruffe N (1995) Influence of peroxisome proliferators on phosphoprotein levels in human and rat hepatic-derived cell lines. Eur J Biochem 230: 316-321
23. Reddy JK, Rao MS, Azarnoff DL, Sell S (1979) Mitogenic and carcinogenic effects of a hypolipidemic peroxisome proliferator Wy-14,643 in rat and mouse liver. Cancer Res 39: 152-160
24. Roberts RA (1996) In: Reddy JK, Suga T, Mannaerts GP, Lazarow PB, Subramani S (eds) Peroxisomes: biology and role in toxicology and disease, vol. 804. New York pp 588-602
25. Roberts RA, Hickman JA, Nebert DW, Richburg JH, Goldsworthy TL (1997) Perturbation of the mitosis apoptosis balance: a fundamental mechanism in toxicology. Symposium overview. Fundam Appl Toxicol 38: 107-115
26. Ruch RJ, Klaunig JE (1988) Kinetics of phenobarbital inhibition of intercellular communication in mouse hepatocytes Cancer Res 48: 2519-2523
27. SAS (1989) SAS/STAT user's guide, vol 2. SAS Institute Incorporated, Cary, NC
28. Schulte-Hermann R (1979) Adaptive liver growth induced by xenobiotic compounds: its nature and mechanism. Arch Toxicol (Suppl) 2: 113-124
29. Seglen PO (1973) Preparation of rat liver cells. III. Enzymatic requirements for tissue dispersion. Exp Cell Res 82: 391-398
30. Shackleton GL, Gibson GG, Sharma RK, Howes D, Orrenius S, Kass GEN (1995) Diverse mechanisms of calcium mobilization by peroxisome proliferators in rat hepatocytes. Toxicol Appl Pharmacol 130: 294-303
31. Spray DC, Fujita M, Saez JC (1987) Proteoglycans and glycos-aminoglycans induce gap junction synthesis and function in primary liver cultures. J Cell Biol 105: 541-551
32. Styles JA, Kelly M, Pritchard NR, Elcombe CR (1988) A species comparison of acute hyperplasia induced by the peroxisome proliferator methylclofenapate: involvement of the binucleated hepatocyte. Carcinogenesis 9: 1647-1655
33. Trosko JE, Chang CC, Madhukar BV, Klaunig JE (1990) Chemical, oncogene and growth factor inhibition of gap junctional intercellular communication: an integrative hypothesis of carcinogenesis. Pathobiology 58: 265-278
34. Tsuda H, Asumoto M, Baba H, Iwahori Y, Matsumoto K, Iwase T, Nishida Y, Nagao S, Hakoi K, Yamaguchi S, Ozaki K, Yamasaki H (1995) Cell proliferation and advancement of hepatocarcinogenesis in the rat are associated with a decrease in connexin 32 expression. Carcinogenesis 16: 101-105
35. Wilhelmina CM, Duivenvoorden PM (1994) Nongenotoxic carcinogens shift cultured rat hepatocytes into G1 cell cycle phase: influence of tissue tension on cells with different ploidy. Eur J Cell Biol 64: 368-375
36. Yamasaki H (1990) Gap junctional intercellular communication and carcinogenesis. Carcinogenesis 11: 1051-1058
37. Yamasaki H, Krutovskikh V, Mesnil M, Tsuda H, Ito N (1993) Gap junctional intercellular communication and cell proliferation during rat liver carcinogenesis. Environ Health Perspect 101: 191-198